Phase III study to evaluate the efficacy and safety of tigulixostat in gout patients with hyperuricemia.
The main criteria that the patient must meet:As part of the study, patients are under constant care of the attending physician, receive free treatment and have free full diagnostics included in the clinical trial. The patient receives reimbursement for travel costs for each visit.
Phase 3 study evaluating the efficacy and safety of deucravacitinib in patients with active psoriatic arthritis not treated with disease-modifying biologics.
The main criteria that the patient must meet:As part of the study, patients are under the constant care of the attending physician, receive free treatment and have free full diagnostics. The patient is reimbursed for travel expenses for each visit.
Phase III study to prove the additional benefit of full-spectrum hemp extract VER-01 over opioids in the treatment of patients with chronic non-specific low back pain.
Main criteria::As part of the examination, the patient undergoes full diagnostics at each visit. The patient is also reimbursed for travel expenses for each visit.
Phase III study for patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis.
Main criteria:As part of the study, patients have full diagnostics and spirometric tests.
Phase III study to evaluate the effectiveness of the study drug in participants with active dermatomyositis or polymyositis.
Main criteria:As part of the study, patients are under constant care of the attending physician, receive free treatment and have free full diagnostics included in the clinical trial. The patient receives reimbursement for travel costs for each visit.
Phase III study evaluating the efficacy, safety and tolerability of the study drug in the form of tablets for patients with generalized systemic sclerosis.
Main criteria:As part of the study, patients are under the constant care of the attending physician, receive free treatment and have free full diagnostics (Spirometry, HRCT, echocardiography and DLCO test). The patient is reimbursed for travel expenses for each visit.
Phase III trial evaluating the effectiveness of PCSK9 in reducing major adverse cardiovascular events in participants at high cardiovascular risk.
Main criteria:As part of the study, patients are under constant care of the attending physician, receive free treatment and have free full diagnostics included in the clinical trial. The patient receives reimbursement for travel costs for each visit.
Phase III study to evaluate the effectiveness of isocibep for patients with moderate to severe acne inversa.
Main criteria:As part of the study, patients are under constant care of the attending physician, receive free treatment and have free full diagnostics included in the clinical trial. The patient receives reimbursement for travel costs for each visit.
Phase Ib study assessing, among others, safety and tolerability of two different doses of the drug tested in patients with atopic dermatitis.
Main criteria:As part of the study, patients are under constant care of the attending physician, receive free treatment and have free full diagnostics included in the clinical trial. The patient receives reimbursement for travel costs for each visit.
Randomized, placebo-controlled, double-blind Phase 3 study evaluating the efficacy, safety, and tolerability of Upadacitinib in adults and adolescents with vitiligo.
Main criteria:As part of the study, patients are under constant care of the attending physician, receive free treatment and have free full diagnostics included in the clinical trial. The patient receives reimbursement for travel costs for each visit.